drugset / Trial / NCT06834594

Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome

NCT06834594

Phase 4 Recruiting 40 enrolled Children's Mercy Hospital Kansas City
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).

Timeline

Start
2025-07-31
Primary completion
2026-07-30
Completion
2026-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 100 mg Oral
Comparator Progesterone Other / unclassified 200 mg Oral

Indications